Additionally, in AML cell lines and AML blasts from patients, CD99 targeting affects cell metabolism by reducing glycolysis and mitochondrial respiration, paving the way for combinations with metabolically active drugs [84]. This evidence concerns the gene CD99 and acute myeloid leukemia.